- Recent Advances in Palliative Chemotherapy for Unresectable Pancreatic Cancer
-
Ryu JK
- KMID: 2373330
- Korean J Gastroenterol.
- 2015 Sep;66(3):150-153.
- doi: 10.4166/kjg.2015.66.3.150
Pancreatic adenocarcinoma is one of the fatalist malignancies. A large proportion of patients are diagnosed with unresectable stage pancreatic cancer at the time of presentation. Gemcitabine is a standard chemotherapeutic... -
- CITED
-
- Close
- SHARE
-
- Close
- Antiviral Therapy in Hepatitis B Carriers Undergoing Immunosuppressive Treatment or Cytotoxic Chemotherapy
-
Yoon JH
- KMID: 760574
- Korean J Hepatol.
- 2005 Mar;11(1):17-20.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Diagnosis and therapy of multiple myeloma
-
Palumbo A, Cerrato C
- KMID: 1776445
- Korean J Intern Med.
- 2013 May;28(3):263-273.
- doi: 10.3904/kjim.2013.28.3.263
Many advances in the treatment of multiple myeloma have been made due to the use of transplantation and the introduction of novel agents including thalidomide, lenalidomide, and bortezomib. The first... -
- CITED
-
- Close
- SHARE
-
- Close
- Clear cell carcinoma of the ovary: molecular insights and future therapeutic perspectives
-
Mabuchi S, Sugiyama T, Kimura T
- KMID: 2363325
- J Gynecol Oncol.
- 2016 May;27(3):e31.
- doi: 10.3802/jgo.2016.27.e31
Clear cell carcinoma (CCC) of the ovary is known to show poorer sensitivity to chemotherapeutic agents and to be associated with a worse prognosis than the more common serous adenocarcinoma... -
- CITED
-
- Close
- SHARE
-
- Close
- Gastric Metastasis from Breast Cancer
-
Yoon SY, Shim KN
- KMID: 1775789
- Korean J Gastroenterol.
- 2013 Jan;61(1):54-57.
- doi: 10.4166/kjg.2013.61.1.54
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Rare Frameshift Mutation Cys475Tyrfs*11 in the BCR/ABL Kinase Domain Contributes to Imatinib Mesylate Resistance in 2 Korean Patients with Chronic Myelogenous Leukemia
-
Park SH, Chi HS, Kwon MR, Cho YU, Jang S, Park CJ
- KMID: 2434491
- Ann Lab Med.
- 2012 Nov;32(6):452-454.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Discrepant Results for BRAF V600E Mutation Among Different Specimens in a Case of Hairy Cell Leukemia
-
Moon HW, Hur M, Han SH, Yun YM, Kim SY
- KMID: 1707241
- Ann Lab Med.
- 2013 Jul;33(4):300-303.
- doi: 10.3343/alm.2013.33.4.300
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- A Case with Coexistence of Major and Minor BCR/ABL Fusion Transcript at Lymphoblastic Crisis of Chronic Myelogenous Leukemia in Patients with Major BCR/ABL Positivity during Chronic Phase
-
Park SH, Chi HS, Cho YU, Jang S, Park CJ, Im HJ
- KMID: 1781303
- Ann Lab Med.
- 2013 Jan;33(1):80-83.
- doi: 10.3343/alm.2013.33.1.80
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- A Rare Case of Chronic Myelogenous Leukemia and Plasma Cell Myeloma in the Same Patient
-
Ahn S, Park JS, Han JH, Cho SR
- KMID: 2363213
- Ann Lab Med.
- 2015 May;35(3):370-372.
- doi: 10.3343/alm.2015.35.3.370
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Persistent suboptimal molecular response in a patient with chronic myelogenous leukemia and Klinefelter syndrome
-
Chakraborty R, Mukkamalla SKR, Singam K, Calderon N
- KMID: 2070143
- Korean J Intern Med.
- 2014 Nov;29(6):827-829.
- doi: 10.3904/kjim.2014.29.6.827
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Two Cases of Acute Lymphoblastic Leukemia with an e1a3 BCR-ABL1 Fusion Transcript
-
Shin SY, Cho JH, Kim HJ, Jang JH, Lee ST, Kim SH
- KMID: 2363168
- Ann Lab Med.
- 2015 Jan;35(1):159-161.
- doi: 10.3343/alm.2015.35.1.159
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Two Lung Masses with Different Responses to Pemetrexed
-
Park KY, Jung JW, Nam SB, Lee HJ, Kim HS, Choi YH, Lee JC
- KMID: 1785681
- Korean J Intern Med.
- 2010 Jun;25(2):213-216.
- doi: 10.3904/kjim.2010.25.2.213
We described here a patient who had two lung masses. Although the two masses had the same histology and a similar good response to initial chemotherapy with gemcitabine and carboplatin,... -
- CITED
-
- Close
- SHARE
-
- Close
- Second Line Chemotherapy for Pancreatic Cancer
-
Park JY
- KMID: 1718400
- Korean J Gastroenterol.
- 2011 Apr;57(4):207-212.
- doi: 10.4166/kjg.2011.57.4.207
Pancreatic cancer is a very lethal cancer. It is the 5th most common cause for cancer related mortality in Korea. Most of patients have unresectable pancreatic cancer, and systemic chemotherapy... -
- CITED
-
- Close
- SHARE
-
- Close
- Safety of Megestrol Acetate in Palliating Anorexia-Cachexia Syndrome in Patients with Castration-Resistant Prostate Cancer
-
Hong S, Jeong IG, You D, Lee JL, Hong JH, Ahn H, Kim CS
- KMID: 1777555
- J Korean Med Sci.
- 2013 May;28(5):687-692.
- doi: 10.3346/jkms.2013.28.5.687
There are concerns whether megestrol acetate (MA) stimulates the growth of prostate cancer in castration-resistant prostate cancer (CRPC). We evaluated the effect of cumulative doses of MA on the disease-specific... -
- CITED
-
- Close
- SHARE
-
- Close
- Chemotherapy for Colorectal Cancer
-
Hong YS, Kim TW
- KMID: 1775934
- Korean J Gastroenterol.
- 2009 Dec;54(6):355-363.
- doi: 10.4166/kjg.2009.54.6.355
Recent advances in chemotherapy lead to improved survival outcomes in patients with colorectal cancer. The 5-fluorouracil (5-FU) is still one of the important chemotherapeutic agents since 1950s, but the introduction... -
- CITED
-
- Close
- SHARE
-
- Close
- Improving survival after endometrial cancer: the big picture
-
Kwon JS
- KMID: 2160810
- J Gynecol Oncol.
- 2015 Jul;26(3):227-231.
- doi: 10.3802/jgo.2015.26.3.227
To improve survival in women with endometrial cancer, we need to look at the "big picture" beyond initial treatment. Although the majority of women will be diagnosed with early stage... -
- CITED
-
- Close
- SHARE
-
- Close
- Management of Hepatocellular Carcinoma: Current Status and Future Directions
-
Au JS, Frenette C
- KMID: 2160627
- Gut Liver.
- 2015 Jul;9(4):437-448.
- doi: 10.5009/gnl15022
Hepatocellular carcinoma (HCC) is the second most common cause of cancer death worldwide. This cancer commonly arises against a background of chronic liver disease. As a result, a patient with... -
- CITED
-
- Close
- SHARE
-
- Close
- Programmed death-1 pathway blockade produces a synergistic antitumor effect: combined application in ovarian cancer
-
Zhu X, Lang J
- KMID: 2413224
- J Gynecol Oncol.
- 2017 Sep;28(5):e64.
- doi: 10.3802/jgo.2017.28.e64
Programmed death-1 (PD-1) and its ligand are part of the immune checkpoint pathway that down-regulates effector T cells in immune response, thereby causing immune suppression. The PD-1/programmed death-ligand 1 (PD-L1)... -
- CITED
-
- Close
- SHARE
-
- Close
- Current Status of Molecular Targeted Therapies in Hepatocellular Carcinoma
-
Suh SJ, Yim HJ
- KMID: 1501636
- Korean J Gastroenterol.
- 2013 Mar;61(3):136-146.
- doi: 10.4166/kjg.2013.61.3.136
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer death in Korea. Curative treatment is only possible when the disease is diagnosed at the early stage. The prognosis... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of petroleum ether extract of Panax ginseng roots on proliferation and cell cycle progression of human renal cell carcinoma cells
-
Sohn J, Lee CH, Chung DJ, Park SH, Kim IS, Hwang WI
- KMID: 754987
- Exp Mol Med.
- 1998 Mar;30(1):47-51.
Panax ginseng roots have long been used as a medicinal herb in oriental countries. We have investigated anti-proliferative effects of lipid soluble Panax ginseng components on human renal cancer cell lines. Petroleum... -
- CITED
-
- Close
- SHARE
-
- Close
